Lexpos News

Community Pharmacy England would like to remind pharmacy owners of the correct use of the exemption reason ‘Was prescribed free-of-charge STI sexual health medication’ coded ‘0017’. This follows information provided by the NHS Business Services Authority (NHSBSA) indicating that in February 2025, 575 EPS prescription items were submitted with the EPS exemption code ‘0017’ without [...]

The post Guidance on the correct use of the ‘FS’ (0017) exemption category appeared first on Community Pharmacy England.

Community Pharmacy England has released an IT update and a summary of the June 2025 meeting of the Community Pharmacy IT Group (CP ITG).  The group are due to consider several key topics, including: Pharmacy IT development current workstreams Electronic Prescription Service (EPS) developments Use of artificial intelligence Get involved Primary Care Cyber Security Readiness: [...]

The post Pharmacy IT workstreams update published as IT group meets appeared first on Community Pharmacy England.

The following price concession granted in May 2025 has rolled over to June 2025: Drug Pack size May 2025 price concession Fluticasone 400microgram/unit dose nasal drops 30 £17.22 Please note any rolled over prices can be adjusted upwards if we receive reports from pharmacy owners to indicate suppliers’ selling prices have increased. The review can [...]

The post Rolled over price concession for June 2025 appeared first on Community Pharmacy England.

Important regulatory changes to the community pharmacy sector – including those on distance selling premises (DSP) pharmacies and core opening hours – have been laid before Parliament today (2 June 2025) and will come into force in 21 days, on 23 June 2025. The amendment regulations make changes to the NHS (Pharmaceutical and Local Pharmaceutical [...]

The post DSP market entry to close plus core opening hours and other regulatory changes appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Notification: Various Products (Zentiva Pharma UK Limited) Date issued: 2 June 2025 Zentiva Pharma UK Limited has informed the MHRA that the batches of soluble or effervescent tablets listed in the annexes are taking longer than expected to fully dissolve, resulting in an increase in residual material being observed. Additionally, some [...]

The post MHRA Class 4 Medicines Notification Various Products (Zentiva Pharma UK Limited) appeared first on Community Pharmacy England.